Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Common Equity (2016 - 2025)

Historic Common Equity for Avricore Health (AVCRF) over the last 17 years, with Q3 2025 value amounting to $939600.5.

  • Avricore Health's Common Equity fell 4849.74% to $939600.5 in Q3 2025 from the same period last year, while for Sep 2025 it was $939600.5, marking a year-over-year decrease of 4849.74%. This contributed to the annual value of $1.4 million for FY2024, which is 347.66% down from last year.
  • Avricore Health's Common Equity amounted to $939600.5 in Q3 2025, which was down 4849.74% from $1.2 million recorded in Q2 2025.
  • Avricore Health's 5-year Common Equity high stood at $21.3 million for Q2 2021, and its period low was $939600.5 during Q3 2025.
  • For the 5-year period, Avricore Health's Common Equity averaged around $6.5 million, with its median value being $1.6 million (2022).
  • Its Common Equity has fluctuated over the past 5 years, first tumbled by 9363.25% in 2022, then skyrocketed by 141045.55% in 2023.
  • Quarter analysis of 5 years shows Avricore Health's Common Equity stood at $1.7 million in 2021, then fell by 16.98% to $1.4 million in 2022, then grew by 1.98% to $1.5 million in 2023, then fell by 4.55% to $1.4 million in 2024, then crashed by 33.3% to $939600.5 in 2025.
  • Its Common Equity was $939600.5 in Q3 2025, compared to $1.2 million in Q2 2025 and $1.4 million in Q1 2025.